Keywords: schering-plough, ends, troubled, lift, clarinex, gets, approval
Schering-Plough ends troubled year with a lift as Clarinex gets US approval
Article | 27 December 2001
Schering-Plough received an early Christmas present on December 21 afterthe US Food and Drug Administration finally approved its new-generation antihistamine product ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Is failure to adopt business process management putting the pharma industry at risk?
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
